| GTO ID | GTC2592 |
| Trial ID | NCT04747093 |
| Disease | B-Cell Lymphoma | B-Cell Acute Lymphoblastic Leukemia |
| Therapy | CAR-NK cell |
| Treatment | CAR-ITNK cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Induced-T Cell Like NK Cells for B Cell Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | Nanfang Hospital, Southern Medical University |
| Other ID(s) | ITNK-2021 |
| Cohort 1 | |||||||
|
|||||||